From Blood Plasma to Drugs
Blood saves life - in many ways.
The manufacture of pharmaceutical
products from blood plasma by
plasma fractionation requires process conditions that are extremely kind
to the product. These products are manufactured under sterile conditions
that require materials and processing of the highest quality. In addition,
the process has to comply with a large number of national and
international standards and statutory provisions.
Manufacturers, therefore, expect great precision in the manufacture and
assembly of their process plants. Every detail of the design must comply with
high-quality standard to avoid production errors. Using
high-performance processing equipment helps guarantee reliable production.
All Production Steps from one Source
As a competent manufacturer of complete plants for the pharmaceutical
industry, GEA Diessel offers you full service to meet every specification.
From the planning, development and installation of your new process plant all
the way to qualification and maintenance - our experienced engineers
will work with your project team to develop innovative and efficient
process technologies for your very individual blood plasma processing
applications.
Performance and Quality
Whatever it is you need your process plant for: the fractionation and
manufacture of products from immunoglobulins, human albumins, Factor VIII,
Factor IX or whatever - our wide range of plant concepts will provide the
equipment you need to meet any requirements or conditions.
By using the
most advanced manufacturing concepts for vessels and skids and the latest
components and valve technology, we ensure that your plant manufactures your
products economically and in a way thatīs kind to the source materials too.
For detailed information please refer to our brochure "Process plant for pharmaceutical and
biotechnology industries".